Viewing Study NCT00872950


Ignite Creation Date: 2025-12-24 @ 4:57 PM
Ignite Modification Date: 2025-12-30 @ 8:00 PM
Study NCT ID: NCT00872950
Status: APPROVED_FOR_MARKETING
Last Update Posted: 2022-04-11
First Post: 2009-03-30
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: 3,4-Diaminopyridine Use in Lambert-Eaton Myasthenic Syndrome(LEMS) and Congenital Myasthenic Syndromes (CMS)
Sponsor: Lahey Clinic
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Eligibility Module Contacts Locations Module References Module